Literature DB >> 5542005

On the mode of action of lipid-lowering agents. V. Kinetics of the inhibition in vitro of rat acetyl coenzyme A carboxylase.

M E Maragoudakis, H Hankin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5542005

Source DB:  PubMed          Journal:  J Biol Chem        ISSN： 0021-9258            Impact factor:   5.157


× No keyword cloud information.
  9 in total

1.  p-Chlorophenoxyisobutyrate enhanced retention of homologous lipoproteins by human aortic smooth muscle cells.

Authors:  I Filipovic; E Buddecke
Journal:  Lipids       Date:  1977-12       Impact factor: 1.880

Review 2.  A review of studies on the mode of action of clofibrate and betabenzalbutyrate.

Authors:  H J Fallon; L L Adams; R G Lamb
Journal:  Lipids       Date:  1972-02       Impact factor: 1.880

3.  Comparative studies on the action of the optical antipodes of the hypolipidaemic aryloxyalkanoic acid, CH 13,437, on liver enzymes of the rat.

Authors:  U Schacht; K Schmitt; E Granzer
Journal:  Experientia       Date:  1972-07-15

4.  The hypolipidemic effect of SU-13,437 in rats with natural endogenous hypertriglyceridemia.

Authors:  P H Lenz; A I Fleischman
Journal:  Lipids       Date:  1971-11       Impact factor: 1.880

5.  Inhibition by 5-(tetradecyloxy)-2-furoic acid of fatty acid and cholesterol synthesis in isolated rat hepatocytes.

Authors:  E Panek; G A Cook; N W Cornell
Journal:  Lipids       Date:  1977-10       Impact factor: 1.880

6.  Antiviral activity of antilipidemic compounds on herpes simplex virus type 1.

Authors:  J K Mehl; D T Witiak; V V Hamparian; J H Hughes
Journal:  Antimicrob Agents Chemother       Date:  1980-08       Impact factor: 5.191

7.  Effect of halofenate and clofibrate on growth and lipid synthesis in Saccharomyces cerevisiae.

Authors:  M D Greenspan; J I Germershausen
Journal:  J Bacteriol       Date:  1973-02       Impact factor: 3.490

8.  Mode of inhibition of mitochondrial energy transduction by chlorophenoxyisobutyrate.

Authors:  S R Panini; C K Kurup
Journal:  Biochem J       Date:  1974-08       Impact factor: 3.857

9.  Rosiglitazone and bezafibrate modulate gene expression in a rat model of non-alcoholic fatty liver disease--a historical prospective.

Authors:  Hemda Schmilovitz-Weiss; Edith Hochhauser; Michal Cohen; Yelena Chepurko; Smadar Yitzhaki; Ehud Grossman; Avshalom Leibowitz; Zvi Ackerman; Ziv Ben-Ari
Journal:  Lipids Health Dis       Date:  2013-03-25       Impact factor: 3.876
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.